Rezultati - Nicholas C. Richardson

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma

    FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma od Nicholas C. Richardson, Yvette L. Kasamon, Haiyan Chen, R. Angelo de Claro, Jingjing Ye, Gideon M. Blumenthal, Ann T. Farrell, Richard Pazdur

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

    Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies od Andrew D.J. Pearson, Elly Barry, Yaël P. Mossé, Franca Ligas, Nick Bird, Teresa de Rojas, Zachary Zimmerman, Keith D. Wilner, Willi Woessmann, Susan Weiner, Brenda J. Weigel, Rajkumar Venkatramani, D Valteau, Toby N. Trahair, Malcolm A. Smith, Sonia Singh, Giovanni Selvaggi, Nicole Scobie, Gudrun Schleiermacher, Nicholas C. Richardson, Julie Park, Karsten Nysom, Koen Norga, Margret Merino, Joe McDonough, Yousif Matloub, Lynley V. Marshall, Eric Lowe, Giovanni Lesa, Meredith S. Irwin, Dominik Karres, Amar Gajjar, François Doz, Elizabeth Fox, Steven G. DuBois, Martha Donoghue, Michela Casanova, Hubert Caron, Victoria Buenger, Diana Bradford, P. Blanc, Amy Barone, Gregory H. Reaman, Gilles Vassal

    Izdano 2021
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: